Gender (male) | 134 (64.7) | Previous IBD-related hospitalization | 131 (63.3) |
Age (yr), mean±SD | 39.63+13.16 | Previous IBD-related surgery | 76 (36.7) |
Age range (yr) | | Previous relapse | 178 (86.0) |
≤29 | 52 (25.1) | Medications | |
30-39 | 63 (30.4) | 5-ASA | 162 (78.3) |
40-49 | 46 (22.2) | Immunomodulators | 128 (61.8) |
50-59 | 28 (13.5) | Biologics | 94 (45.4) |
≥60 | 18 (8.7) | Steroids | 11 (5.3) |
Married | 113 (54.6) | Route of medications | |
Living status | | PO only | 121 (58.5) |
With family member(s) | 182 (87.9) | PO and parenteral | 86 (41.5) |
Alone | 22 (10.6) | Number of medications | |
With others | 3 (1.5) | One | 104 (50.2) |
Education level | | More than two | 103 (49.8) |
≤High school | 48 (23.2) | Number of pills (per day), mean±SD | 6.21+3.97 |
≥Bachelor's degree | 159 (76.8) | Number of pills (per day) | |
Religion | | <5 | 73 (35.3) |
Yes | 88 (42.5) | ≥5 | 134 (64.7) |
No | 119 (57.5) | Number of doses (per day) | |
Occupation | | Once | 66 (31.9) |
Yes | 140 (67.6) | Twice | 66 (31.9) |
No | 67 (32.4) | Three or more times | 75 (36.2) |
Monthly household income (Korean won) | | Outpatient visit interval (days), mean±SD | 73.77+35.66 |
<3 million | 86 (41.5) | Outpatient visit interval (days) | |
≥3 million | 121 (58.5) | <28 | 31 (15.0) |
Smoking | | 28-56 | 65 (31.4) |
Yes | 28 (13.5) | 57-84 | 40 (19.3) |
No | 179 (86.5) | ≥85 | 71 (34.3) |
Disease | | IBD education experience | 170 (82.1) |
Crohn's disease | 125 (60.4) | Disease activity | |
Ulcerative colitis | 82 (39.6) | Remission | 158 (76.3) |
Disease duration (yr), mean±SD | 10.09+6.33 | Mild | 34 (16.4) |
Disease duration (yr) | | Moderate | 13 (6.3) |
<5 | 50 (24.2) | Severe | 2 (1.0) |
5-9 | 52 (25.1) | | |
10-14 | 64 (30.9) | | |
≥15 | 41 (19.8) | | |